Abstract
Novel gamma-aminobutyric acid (GABA) analogues 3-5, having a bicyclo[3.1.0]hexene, [4.1.0]heptane, or [4.1.0]heptene backbone, respectively, were designed from the bioactive form analysis of the previous inhibitor 2 with a bicyclo[3.1.0]hexane backbone. Compounds 3-5 and 2 were synthesized from a common 1,7-diene intermediate 6 using ring-closing metathesis (RCM) to construct the key bicyclo backbones. Compounds 3-5 strongly inhibit betaine/GABA transporter 1 (BGT1) uptake, but compound 4 stands out with its selective low micromolar potency.
Original language | English |
---|---|
Journal | Organic Letters |
Volume | 24 |
Issue number | 23 |
Pages (from-to) | 4151-4154 |
ISSN | 1523-7060 |
DOIs | |
Publication status | Published - 2022 |
Keywords
- ISOMERIZATION
- CYCLOISOMERIZATION
- CARBENE